Point-of-Care Infectious Disease Diagnostics Market 2025 to 2035
Point-of-Care Infectious Disease Diagnostics Market 2025 to 2035
Point-of-Care Infectious Disease Diagnostics Market (By Technology: Lateral Flow, Agglutination Assays, Flow Through, Solid Phase; By Application: HIV, Liver Disease, Tropical Disease, Inflammatory Disease, Respiratory Disease, Hospital Associated Infections (HAIs), Sexual Health Disorders, Others; By End-user: Hospital, Diagnostic Laboratories, Home-care settings, Others; By Region: North America, Latin America, Europe, Asia-Pacific, Middle and East Africa) Industry Size, Share, Growth, Trends 2025 to 2035.
Customisation Request
Revenue, 2025
USD 6.20 Bn
Forecast Year, 2035
USD 25.66 Bn
CAGR, 2025 - 2035
15.26%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global point-of-care infectious disease diagnostics market is projected to grow from USD 6.20B in 2025 to USD 25.66B by 2035, expanding at a CAGR of 15.26%, driven by rising demand for rapid, on-site testing solutions worldwide.
Point-of-Care Infectious Disease Diagnostics Market Size Analysis
Point-of-Care Infectious Disease Diagnostics Market Size By Technology 2025 to 2035 (USD Billion)
| Technology | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Lateral Flow | 2.73 | 3.14 | 3.62 | 4.18 | 4.82 | 5.55 | 6.40 | 7.37 | 8.50 | 9.80 | 11.29 |
| Agglutination Assays | 1.11 | 1.28 | 1.48 | 1.71 | 1.97 | 2.27 | 2.61 | 3.01 | 3.47 | 4.00 | 4.61 |
| Flow Through | 1.26 | 1.46 | 1.68 | 1.93 | 2.23 | 2.57 | 2.96 | 3.41 | 3.93 | 4.53 | 5.23 |
| Solid Phase | 1.09 | 1.26 | 1.45 | 1.68 | 1.93 | 2.23 | 2.57 | 2.96 | 3.41 | 3.93 | 4.53 |
Point-of-Care Infectious Disease Diagnostics Market Size By Application 2025 to 2035 (USD Billion)
| Application | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HIV | 0.97 | 1.11 | 1.28 | 1.48 | 1.70 | 1.96 | 2.26 | 2.61 | 3.01 | 3.47 | 3.99 |
| Liver Disease | 0.67 | 0.77 | 0.89 | 1.03 | 1.18 | 1.36 | 1.57 | 1.81 | 2.09 | 2.40 | 2.77 |
| Tropical Disease | 0.92 | 1.06 | 1.22 | 1.41 | 1.63 | 1.87 | 2.16 | 2.49 | 2.87 | 3.31 | 3.81 |
| Inflammatory Disease | 0.62 | 0.71 | 0.82 | 0.95 | 1.09 | 1.26 | 1.45 | 1.67 | 1.93 | 2.22 | 2.56 |
| Respiratory Disease | 1.25 | 1.44 | 1.66 | 1.91 | 2.21 | 2.54 | 2.93 | 3.38 | 3.89 | 4.49 | 5.17 |
| Hospital Associated Infections (HAIs) | 0.82 | 0.94 | 1.09 | 1.25 | 1.45 | 1.67 | 1.92 | 2.21 | 2.55 | 2.94 | 3.39 |
| Sexual Health Disorders | 0.64 | 0.73 | 0.84 | 0.97 | 1.12 | 1.29 | 1.49 | 1.72 | 1.98 | 2.28 | 2.63 |
| Others | 0.32 | 0.37 | 0.43 | 0.49 | 0.57 | 0.65 | 0.75 | 0.87 | 1.00 | 1.15 | 1.33 |
Point-of-Care Infectious Disease Diagnostics Market Size By End User 2025 to 2035 (USD Billion)
| End User | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital | 2.93 | 3.37 | 3.89 | 4.48 | 5.17 | 5.95 | 6.86 | 7.91 | 9.12 | 10.51 | 12.11 |
| Diagnostic Laboratories | 1.87 | 2.15 | 2.48 | 2.86 | 3.30 | 3.80 | 4.38 | 5.05 | 5.82 | 6.70 | 7.73 |
| Home-care settings | 0.95 | 1.10 | 1.27 | 1.46 | 1.68 | 1.94 | 2.23 | 2.57 | 2.97 | 3.42 | 3.94 |
| Others | 0.45 | 0.52 | 0.60 | 0.69 | 0.80 | 0.92 | 1.06 | 1.23 | 1.41 | 1.63 | 1.88 |
Point-of-Care Infectious Disease Diagnostics Market Size By Region 2025 to 2035 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2.25 | 2.60 | 2.99 | 3.45 | 3.98 | 4.58 | 5.28 | 6.09 | 7.02 | 8.09 | 9.32 |
| Europe | 1.61 | 1.85 | 2.14 | 2.46 | 2.84 | 3.27 | 3.77 | 4.34 | 5.01 | 5.77 | 6.65 |
| Asia Pacific | 1.51 | 1.74 | 2.00 | 2.31 | 2.66 | 3.06 | 3.53 | 4.07 | 4.69 | 5.41 | 6.23 |
| Latin America | 0.51 | 0.59 | 0.68 | 0.78 | 0.90 | 1.04 | 1.20 | 1.38 | 1.59 | 1.83 | 2.11 |
| Middle East and Africa | 0.32 | 0.37 | 0.43 | 0.50 | 0.57 | 0.66 | 0.76 | 0.87 | 1.01 | 1.16 | 1.34 |
Point-of-Care Infectious Disease Diagnostics Market Size to Surpass USD 25.66 Billion by 2035
The global point-of-care infectious disease diagnostics market size was calculated at USD 6.20 billion in 2025 and is predicted to attain around USD 25.66 billion by 2035 a CAGR of 15.26%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
